Post-approval studies (Phase 4)Study completedNCT00796497
What this trial is testing
Ondansetron in Treatment Resistant Obsessive Compulsive Disorder (OCD)
Who this might be right for
Obsessive Compulsive Disorder
Institute of Neuroscience, Florence, Italy 14